Drug Delivery Solutions Market

Starting at US$ 5000

Buy Now
Infographics Companies
Market Size (2026)
USD 1.2 Bn
Forecast (2036)
USD 2.1 Bn
CAGR (2026 to 2036)
5.8%

Drug Delivery Solutions Market Size, Market Forecast and Outlook By FMI

The drug delivery solutions market was valued at USD 1.1 billion in 2025. The market is set to reach USD 1.2 billion by 2026-end and grow at a CAGR of 5.8% between 2026-2036 to reach USD 2.1 billion by 2036. Primary Packaging Solutions will dominate with a 52.0% share, while Plastic will lead with a 36.0% share.

Drug Delivery Solutions Market Value Analysis
Drug Delivery Solutions Market Value Analysis

Drug Delivery Solutions Market Overview: Size and Forecast

  • Drug Delivery Solutions Market Value (2026): USD 1.2 Bn
  • Drug Delivery Solutions Market Forecast Value (2036): USD 2.1 Bn
  • Drug Delivery Solutions Market Forecast CAGR (2026 to 2036): 5.8%
  • Drug Delivery Solutions Market Leading Product: Primary Packaging Solutions (52.0%)
  • Drug Delivery Solutions Market Key Growth Regions: China, India, Germany, Brazil, USA, UK, Japan
  • Drug Delivery Solutions Market Key Players: Amcor Plc, SCHOTT AG, Gerresheimer AG, Berry Global Group Inc., Mondi Plc, Sealed Air Corp., Wipak Group, Constantia Flexibles, Ardagh Group SA, Sonoco Products Company

Parameter Details
Market Size in 2026 (Value) USD 1.2 Bn
Market Forecast in 2036 (Value) USD 2.1 Bn
CAGR (2026 to 2036) 5.8%
Years Considered 2021 to 2036
Base Year 2025
Forecast Period 2026 to 2036
Units Considered Value (USD Bn)
Leading Sub-Region China

Summary of the Drug Delivery Solutions Market

  • Demand and Growth Drivers
    • Regulatory compliance requirements and hospital procurement cycles are expected to sustain demand for drug delivery solutions products as healthcare facilities upgrade equipment to meet updated standards.
    • Aging population demographics across North America, Europe, and East Asia are projected to support steady adoption rates through the forecast period.
    • Cost containment pressure in institutional healthcare settings is shifting procurement toward products that reduce per-procedure costs and improve clinical throughput.
  • Product and Segment View
    • Primary Packaging Solutions is expected to account for 52.0% of the product segment in 2026, supported by established procurement patterns and end-use demand across commercial and institutional applications.
    • Blister Packaging is projected to gain share during the forecast period as clinical applications expand across emerging markets and specialized use cases.
    • By application, Injectable Drug Delivery is expected to remain the primary demand driver, reflecting established consumption patterns and supply chain structures.
  • Geography and Competitive Outlook
    • China is projected to lead growth at 7.5% through 2036, supported by expanding healthcare infrastructure and regulatory frameworks.
    • India at 6.9% reflects strong institutional demand and regulatory compliance culture during the forecast period.
    • Companies with established manufacturing footprints and direct procurement relationships across high-growth regions are positioned to capture incremental volume during the forecast period.
  • Analyst Opinion
    • Nandini Roy Choudhury, Principal Consultant at FMI says, 'Companies that can align product portfolios with evolving regulatory requirements and institutional procurement standards are expected to strengthen market positioning through 2036.'
    • The drug delivery solutions market is transitioning from a volume-driven phase into a value-driven phase where product performance, compliance readiness, and total cost of ownership are becoming primary procurement criteria.
    • Adoption is increasing due to regulatory tightening, end-use sector expansion, and the replacement of legacy systems and products that no longer meet updated specifications.
    • Demand is further supported by procurement consolidation among large-scale buyers and growing preference for suppliers with integrated manufacturing and distribution capabilities.

Drug Delivery Solutions Market Definition

The drug delivery solutions market encompasses products, solutions, and services used across clinical, institutional, and commercial healthcare applications. The market covers all commercially traded drug delivery solutions products classified by product, material, application, end use, distribution channel, serving end-use sectors that require standardized performance, regulatory compliance, and supply reliability.

Drug Delivery Solutions Market Inclusions

Market scope encompasses all commercially traded drug delivery solutions products categorized by product (Primary Packaging Solutions, Blister Packaging, Flexible Packaging, Advanced Drug Delivery Containers, Caps and Closures), material (Plastic, Glass, Metal, Paper and Paperboard), application (Injectable Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Dermal and Transdermal Delivery), end use (Pharmaceutical Companies, Biotechnology Companies, Contract Manufacturing Organizations, Healthcare Providers), distribution channel (Direct Sales, Distributor Sales, Online Sales). Revenue estimates cover the period from 2026 to 2036 across all regions and distribution channels.

Drug Delivery Solutions Market Exclusions

The scope does not include custom-engineered or one-off products outside standard commercial distribution, raw materials sold as unprocessed inputs, or services not directly tied to drug delivery solutions product procurement and deployment.

Drug Delivery Solutions Market Research Methodology

  • Primary Research: FMI analysts interviewed primary sources from the demand side such as manufacturers, distributors, procurement specialists, and end-use operators in key markets.
  • Desk Research: Assembled trade data, regulatory filings, industry association publications and manufacturer disclosures to establish baseline market parameters.
  • Market sizing and forecasting: Bottom-up aggregation across product, material and regional adoption curves triangulated with top-down macro indicators
  • Data Validation: Quarterly cross-checked with production statistics, trade flow data, and revenue disclosures by manufacturers.

Why is the Drug Delivery Solutions Market Growing?

  • Regulatory compliance upgrades and aging population demographics are sustaining demand for drug delivery solutions products in both established and emerging markets.
  • China is growing at 7.5% with the increasing institutional healthcare capacity and device procurement during the forecast period.
  • Primary Packaging Solutions dominates the product segment with 52.0% share, owing to established demand patterns and wide commercial applicability across clinical settings.

The market for drug delivery solutions is estimated to reach USD 2.1 billion by 2036, growing at a CAGR of 5.8% from USD 1.2 billion in 2026 during the forecast period. The growth is attributed to growing healthcare infrastructure, stringent regulatory requirements and rising adoption of standardized medical products across institutional settings. The incremental opportunity of USD 0.9 Bn from 2026 to 2036 reflects the cumulative impact of replacement cycles, capacity additions, and geographic expansion of procurement networks.

The largest product category is Primary Packaging Solutions, which accounts for 52.0% in 2026. Demand for this segment is focused in hospital, clinic and laboratory settings where standardized product performance and regulatory approval are pre-requisites for procurement. Blister Packaging is a secondary growth category that is gaining share as end-use applications expand into specialized and emerging use cases.

Geographically, the market share is owned by China (7.5%), driven by centralized procurement through the VBP programs. India at 6.9% reflects demand for procurement created by the expansion of Ayushman Bharat coverage. Demand continues to be supported by established markets in North America and Western Europe, through replacement cycles, regulatory updates and institutional procurement.

Market Segmentation Analysis

  • Primary Packaging Solutions leads the product segment at 52.0% in 2026, reflecting established procurement patterns across clinical and institutional applications.
  • By material, Plastic at 36.0% is the primary demand category, supported by broad applicability across end-use sectors.
  • Application structures reflect procurement channel preferences, with direct supply relationships dominating high-volume institutional demand.

The drug delivery solutions market is segmented by product, material, application, end use, distribution channel. Product segmentation reflects the product taxonomy used in commercial procurement, with Primary Packaging Solutions, Blister Packaging, Flexible Packaging, Advanced Drug Delivery Containers, Caps and Closures as the primary categories. Material segmentation captures differentiated demand across Plastic, Glass, Metal, and others.

Insights into the Primary Packaging Solutions Segment

Primary Packaging Solutions occupies 52.0% of the product segment in 2026, indicating established demand in hospital, clinics and diagnostics. The main sub-categories are Bottles, Plastic Bottles, Glass Bottles and others which are used for different end use purposes.

Procurement trends for primary packaging solutions are driven by clinical protocol requirements, reimbursement landscape and institutional purchasing cycles. Growth in the forecast period is expected to be driven by both replacement demand in established markets and additional capacity in emerging regions.

Insights into the Blister Packaging Segment

The product segment is positioned as a growth category with expanding applications in specialized clinical and diagnostic settings. The sub-categories are Unit Dose Blisters, Thermoformed Blisters, Cold Form Blisters with differentiated performance and compliance requirements.

Changing clinical protocols, regulatory amendments and increasing demand for precision-oriented products are seen to increase adoption of blister packaging. The segment is anticipated to grow due to the new installations and upgrades to the existing systems during the forecast period.

Drug Delivery Solutions Market Drivers, Restraints, and Opportunities

  • Regulatory compliance, hospital modernization, and aging demographics are the primary structural drivers supporting demand through 2036.
  • Reimbursement constraints and pricing pressure in institutional procurement represent the main demand-side restraints during the forecast period.
  • Emerging market healthcare expansion and point-of-care adoption are expected to create incremental procurement opportunities.

The drug delivery solutions market is supported by a combination of structural demand drivers, regulatory mandates, and end-use sector expansion that together create a sustained procurement environment through 2036. Restraints include input cost pressures, supply chain concentration risks, and regulatory compliance costs that constrain adoption in price-sensitive market segments.

Regulatory and Compliance-Driven Procurement

Demand is being driven by evolving regulatory requirements across the FDA, EU MDR and regional medical device frameworks. Procurement cycles are recurrent as manufacturers and healthcare facilities comply with updated standards (e.g. product specification updates, labeling requirements, post-market surveillance mandates).

Institutional Replacement and Modernization Cycles

Growth reflects aging installed bases in hospitals and laboratories in North America, Europe and East Asia. During the forecast period, demand is being generated by facilities replacing legacy systems and products to meet updated safety, efficiency, and interoperability standards.

Emerging Market Healthcare Expansion

Investment in healthcare infrastructure in China, India and Southeast Asia is driving growth in adoption. Standardized medical products and devices are finding new procurement channels thanks to government programs, private hospital expansion and growing insurance coverage.

Analysis of Drug Delivery Solutions Market By Key Countries

Top Country Growth Comparison Drug Delivery Solutions Market Cagr (2026 2036)
Top Country Growth Comparison Drug Delivery Solutions Market Cagr (2026 2036)
Country CAGR
China 7.5%
India 6.9%
Germany 6.4%
Brazil 5.8%
USA 5.2%
UK 4.7%
Japan 4.1%
  • China at 7.5% reflects centralized procurement through VBP programs.
  • India at 6.9% reflects private hospital chains investing in modern equipment.
  • Germany at 6.4% reflects strong domestic manufacturing of precision instruments.
  • Brazil at 5.8% reflects import dependency creating opportunities for domestic capacity building.

The global drug delivery solutions market is projected to expand at 5.8% from 2026 to 2036. The study covers more than 30 countries, and the primary markets are listed below.

Drug Delivery Solutions Market Cagr Analysis By Country
Drug Delivery Solutions Market Cagr Analysis By Country

Demand Outlook for Drug Delivery Solutions Market in China

Demand for drug delivery solutions in China is concentrated in institutional healthcare and diagnostic applications, with the market projected to grow at 7.5% through 2036. Growth is attributable to centralized procurement through VBP programs and hospital expansion in tier-2 and tier-3 cities.

  • Centralized procurement through VBP programs is generating procurement demand for primary packaging solutions across clinical and institutional channels.
  • Hospital expansion in tier-2 and tier-3 cities supports adoption of blister packaging as end-use requirements expand.
  • Domestic device manufacturer growth under NMPA pathways is expected to create incremental volume for plastic applications during the forecast period.

Future Outlook for Drug Delivery Solutions Market in India

Ayushman Bharat coverage expansion creating procurement demand in India is creating sustained procurement demand for drug delivery solutions, with the market expanding at 6.9% through 2036. Private hospital chains investing in modern equipment further support adoption across end-use sectors.

  • Ayushman Bharat coverage expansion creating procurement demand is generating procurement demand for primary packaging solutions across clinical and institutional channels.
  • Private hospital chains investing in modern equipment supports adoption of blister packaging as end-use requirements expand.
  • Cost-effectiveness as a procurement priority is expected to create incremental volume for plastic applications during the forecast period.

Opportunity Analysis of Drug Delivery Solutions Market in Germany

Drug Delivery Solutions Market Europe Country Market Share Analysis, 2026 & 2036
Drug Delivery Solutions Market Europe Country Market Share Analysis, 2026 & 2036

Germany's healthcare infrastructure supports a growth rate of 6.4% through 2036. Procurement patterns reflect EU MDR compliance requirements for medical devices and strong domestic manufacturing of precision instruments.

  • EU MDR compliance requirements for medical devices is generating procurement demand for primary packaging solutions across clinical and institutional channels.
  • Hospital procurement through GPO structures supports adoption of blister packaging as end-use requirements expand.
  • Strong domestic manufacturing of precision instruments is expected to create incremental volume for plastic applications during the forecast period.

In-depth Analysis of Drug Delivery Solutions Market in Brazil

Regulatory requirements in Brazil are shaping procurement demand for drug delivery solutions, with the market growing at 5.8% through 2036. Government policy support for industrial development and expanding end-use applications across commercial and institutional segments are the primary demand-side factors.

  • Growing domestic demand and infrastructure investment is generating procurement demand for primary packaging solutions across clinical and institutional channels.
  • Government policy support for industrial development supports adoption of blister packaging as end-use requirements expand.
  • Expanding end-use applications across commercial and institutional segments is expected to create incremental volume for plastic applications during the forecast period.

Sales Analysis of Drug Delivery Solutions Market in USA

Drug Delivery Solutions Market Country Value Analysis
Drug Delivery Solutions Market Country Value Analysis

Infrastructure investment in USA is supporting drug delivery solutions demand at 5.2% through 2036. Growth is led by FDA regulatory pathways and 510(k) clearances and antibiotic stewardship mandates and hospital procurement protocols.

  • FDA regulatory pathways and 510(k) clearances is generating procurement demand for primary packaging solutions across clinical and institutional channels.
  • Antibiotic stewardship mandates and hospital procurement protocols supports adoption of blister packaging as end-use requirements expand.
  • Medicare and Medicaid reimbursement structures is expected to create incremental volume for plastic applications during the forecast period.

Growth Analysis of Drug Delivery Solutions Market in UK

The installed base in UK is mature, with demand sustained at 4.7% through 2036 by replacement cycles and NHS procurement frameworks and NICE assessments. Post-Brexit regulatory alignment with MHRA pathways provide additional procurement support.

  • NHS procurement frameworks and NICE assessments is generating procurement demand for primary packaging solutions across clinical and institutional channels.
  • Post-Brexit regulatory alignment with MHRA pathways supports adoption of blister packaging as end-use requirements expand.
  • Aging population demographics driving device demand is expected to create incremental volume for plastic applications during the forecast period.

Demand Outlook for Drug Delivery Solutions Market in Japan

Demand for drug delivery solutions in Japan is concentrated in institutional healthcare and diagnostic applications, with the market projected to grow at 4.1% through 2036. Growth is attributable to PMDA regulatory pathways and Shonin approval processes and aging population driving sustained device demand.

  • PMDA regulatory pathways and Shonin approval processes is generating procurement demand for primary packaging solutions across clinical and institutional channels.
  • Aging population driving sustained device demand supports adoption of blister packaging as end-use requirements expand.
  • Hospital automation and precision care investment is expected to create incremental volume for plastic applications during the forecast period.

Competitive Landscape and Strategic Positioning

Drug Delivery Solutions Market Analysis By Company
Drug Delivery Solutions Market Analysis By Company
  • Amcor Plc leads the market with established manufacturing and regulatory approval infrastructure across key regions.
  • SCHOTT AG, Gerresheimer AG, Berry Global Group Inc. maintain competitive positions through product portfolio breadth and clinical validation capabilities.
  • Emerging players are focusing on specialized clinical applications and point-of-care segments to gain market entry.

Amcor Plc leads the drug delivery solutions market through broad product portfolios, regulatory approvals across multiple jurisdictions, and established relationships with hospital and laboratory procurement. SCHOTT AG maintains a competitive position through clinical product specialization and diagnostic technology capabilities.

Gerresheimer AG and Berry Global Group Inc. compete on product performance, regulatory compliance, and clinical evidence. Competitive barriers include regulatory approval timelines, clinical validation requirements, and established GPO relationships.

Strategic priorities include expanding product portfolios into adjacent clinical applications, securing regulatory approvals in emerging markets, and improving manufacturing cost structures.

Key Companies in the Drug Delivery Solutions Market

Key global companies leading the drug delivery solutions market include:

  • Amcor Plc, SCHOTT AG, Gerresheimer AG, Berry Global Group Inc., Mondi Plc maintain leading positions through established manufacturing infrastructure, broad product portfolios, and direct procurement relationships across global markets.
  • Sealed Air Corp., Wipak Group, Constantia Flexibles have built competitive positions in regional markets through specialized product capabilities and focused distribution networks.
  • Ardagh Group SA, Sonoco Products Company represent emerging participants with differentiated technology or application focus that positions them for growth in specialized segments.

Competitive Benchmarking: Drug Delivery Solutions Market

Company Product Portfolio Regulatory Coverage Clinical Evidence Geographic Reach
Amcor Plc High High Strong Global
SCHOTT AG High High Strong Global
Gerresheimer AG Medium Medium Moderate Regional
Berry Global Group Inc. Medium Medium Moderate Regional
Mondi Plc Medium Medium Moderate Regional
Sealed Air Corp. Medium Medium Low Regional
Wipak Group Medium Medium Low Regional
Constantia Flexibles Medium Medium Low Regional
Ardagh Group SA Medium Medium Low Regional
Sonoco Products Company Medium Medium Low Regional

Source: Future Market Insights competitive analysis, 2026.

Key Developments in Drug Delivery Solutions Market

  • In 2025, Amcor Plc expanded its drug delivery solutions product portfolio to address updated regulatory requirements and clinical demand across North America and Europe.
  • In 2025, SCHOTT AG secured regulatory clearance for a new primary packaging solutions configuration targeting institutional healthcare applications in high-growth markets.

Key Players in the Drug Delivery Solutions Market

Major Global Players

  • Amcor Plc
  • SCHOTT AG
  • Gerresheimer AG
  • Berry Global Group Inc.
  • Mondi Plc
  • Sealed Air Corp.
  • Wipak Group

Emerging Players/Startups

  • Stevanato Group
  • Credence MedSystems
  • Ypsomed
  • SHL Medical

Report Scope and Coverage

Drug Delivery Solutions Market Breakdown By Product, Material, And Region
Drug Delivery Solutions Market Breakdown By Product, Material, And Region

Drug Delivery Solutions Market - Research Methodology

Method Description
Primary Research FMI analysts interviewed primary sources from the demand side such as manufacturers, distributors, procurement specialists, and end-use operators in key markets.
Desk Research Assembled trade data, regulatory filings, industry association publications and manufacturer disclosures to establish baseline market parameters.
Market Sizing & Forecasting Bottom-up aggregation across product, material and regional adoption curves triangulated with top-down macro indicators
Data Validation Quarterly cross-checked with production statistics, trade flow data, and revenue disclosures by manufacturers.
Parameter Details
Market size by 2036 USD 2.1 Bn
Growth rate 5.8% CAGR (2026 to 2036)
Forecast period 2026 to 2036
Base year value (2025) USD 1.1 Bn
Key Segment Covered Product, Material, Application, End Use, Distribution Channel
Regions covered North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries covered USA, China, India, Germany, Brazil, UK, Japan, 30 plus countries
Key companies profiled Amcor Plc, SCHOTT AG, Gerresheimer AG, Berry Global Group Inc., Mondi Plc, Sealed Air Corp., Wipak Group, Constantia Flexibles, Ardagh Group SA, Sonoco Products Company

Market Segmentation Analysis

Drug Delivery Solutions Market Segmented by Product:

  • Primary Packaging Solutions
    • Bottles
      • Plastic Bottles
      • Glass Bottles
    • Vials and Ampoules
      • Glass Vials
      • Glass Ampoules
  • Blister Packaging
    • Unit Dose Blisters
      • Thermoformed Blisters
      • Cold Form Blisters
  • Flexible Packaging
    • Bags and Pouches
      • Intravenous Bags
      • Stand Up Pouches
    • Sachets
      • Single Dose Sachets
      • Multi Dose Sachets
  • Advanced Drug Delivery Containers
    • Prefilled Syringes and Cartridges
      • Glass Prefilled Syringes
      • Polymer Prefilled Syringes
      • Cartridges for Pen Injectors
    • Tubes
      • Aluminum Tubes
      • Laminated Tubes
  • Caps and Closures
    • Standard Closures
      • Screw Caps
      • Snap On Caps
    • Specialty Closures
      • Child Resistant Closures
      • Tamper Evident Closures

Drug Delivery Solutions Market Segmented by Material:

  • Plastic
    • Polyethylene
      • High Density Polyethylene
      • Low Density Polyethylene
    • Polypropylene
      • Medical Grade Polypropylene
      • High Clarity Polypropylene
  • Glass
    • Type I Borosilicate Glass
      • Vials and Ampoules
      • Prefilled Syringes
    • Type II and III Glass
      • Bottles
      • Cartridges
  • Metal
    • Aluminum
      • Tubes
      • Caps
    • Stainless Steel
      • Specialty Containers
      • Aerosol Components
  • Paper and Paperboard
    • Carton Packaging
      • Folding Cartons
      • Corrugated Boxes
    • Flexible Paper Packaging
      • Sachets
      • Medical Grade Paper Packs

Drug Delivery Solutions Market Segmented by Application:

  • Injectable Drug Delivery
    • Intravenous Delivery
      • Infusion Therapy
      • Hospital Administration
    • Subcutaneous Delivery
      • Self Administration Devices
      • Auto Injector Systems
  • Pulmonary Drug Delivery
    • Dry Powder Inhalation
      • Capsule Based Inhalers
      • Reservoir Inhalers
    • Metered Dose Inhalation
      • Pressurized Inhalers
      • Breath Actuated Inhalers
  • Nasal Drug Delivery
    • Unit Dose Systems
      • Spray Devices
      • Dropper Systems
    • Multi Dose Systems
      • Metered Spray Pumps
      • Preservative Based Systems
  • Ophthalmic Drug Delivery
    • Eye Drops
      • Multi Dose Bottles
      • Unit Dose Vials
    • Ointments and Gels
      • Sterile Tubes
      • Single Use Packs
  • Dermal and Transdermal Delivery
    • Topical Delivery
      • Creams and Ointments
      • Gels and Lotions
    • Transdermal Systems
      • Patches
      • Advanced Drug Release Systems

Drug Delivery Solutions Market Segmented by End Use:

  • Pharmaceutical Companies
    • Branded Drug Manufacturers
      • Innovator Companies
      • Specialty Pharma
    • Generic Drug Manufacturers
      • Large Scale Generics
      • Contract Manufacturers
  • Biotechnology Companies
    • Biologics Manufacturers
      • Monoclonal Antibodies
      • Vaccines
    • Cell and Gene Therapy Companies
      • Advanced Therapies
      • Personalized Medicine
  • Contract Manufacturing Organizations
    • Fill and Finish Services
      • Aseptic Filling
      • Sterile Packaging
    • Packaging Services
      • Primary Packaging
      • Secondary Packaging
  • Healthcare Providers
    • Hospitals
      • Inpatient Care
      • Outpatient Care
    • Clinics
      • Specialty Clinics
      • Primary Care Centers

Drug Delivery Solutions Market Segmented by Distribution Channel:

  • Direct Sales
    • Manufacturer Direct Supply
      • Bulk Procurement Contracts
      • Long Term Agreements
  • Distributor Sales
    • Medical Distributors
      • Regional Distributors
      • National Distributors
  • Online Sales
    • Digital Procurement Platforms
      • Hospital Procurement Systems
      • E Marketplace Platforms

Drug Delivery Solutions Market by Region:

  • North America
    • USA
    • Canada
    • Mexico
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Western Europe
    • Germany
    • UK
    • Italy
    • Spain
    • France
    • Nordic
    • BENELUX
    • Rest of Western Europe
  • Eastern Europe
    • Russia
    • Poland
    • Hungary
    • Balkan & Baltic
    • Rest of Eastern Europe
  • East Asia
    • China
    • Japan
    • South Korea
  • South Asia and Pacific
    • India
    • ASEAN
    • Australia & New Zealand
    • Rest of South Asia and Pacific
  • Middle East & Africa
    • Kingdom of Saudi Arabia
    • Other GCC Countries
    • Türkiye
    • South Africa
    • Other African Union
    • Rest of Middle East & Africa

Research Sources and Bibliography

  • 1. World Health Organization. (2025). WHO Global Report on Medical Device Procurement and Access. WHO.
  • 2. USA Food and Drug Administration. (2025). FDA Medical Device Approvals and Clearances Database. FDA.
  • 3. European Medicines Agency. (2025). EMA Annual Report on Medical Device Regulation. EMA.
  • 4. International Medical Device Regulators Forum. (2025). IMDRF Guidance on Device Classification and Market Access. IMDRF.
  • 5. Organisation for Economic Co-operation and Development. (2025). OECD Health Statistics: Medical Technology Indicators. OECD.

This bibliography is provided for reader reference.

This Report Answers

  • Estimating the size of the drug delivery solutions market and revenue projections from 2026 to 2036.
  • Segmentation by product, material, application, end use, distribution channel.
  • Insights across more than 30 regional and country-level markets.
  • Analysis of clinical adoption, regulatory landscape, and institutional procurement patterns.
  • Assessment of the competitive landscape and company benchmarking.
  • Identification of growth opportunities across product and material segments.
  • Evaluation of supply chain dynamics and distribution channel structures.
  • Delivery of data in PDF and Excel formats.

Frequently Asked Questions

How big is the drug delivery solutions market in 2026?

The global drug delivery solutions market is estimated to be valued at USD 1.2 billion in 2026.

What will be the size of the drug delivery solutions market in 2036?

The market size for the drug delivery solutions market is projected to reach USD 2.1 billion by 2036.

How much will the drug delivery solutions market grow between 2026 and 2036?

The drug delivery solutions market is expected to grow at a 5.8% CAGR between 2026 and 2036.

What are the key products in the drug delivery solutions market?

The key products in the drug delivery solutions market are Primary Packaging Solutions, Blister Packaging, Flexible Packaging, Advanced Drug Delivery Containers and Caps and Closures.

Which material segment is expected to contribute a significant share in the drug delivery solutions market in 2026?

In terms of material, the plastic segment is expected to command 36.0% share in the drug delivery solutions market in 2026.

Preview the report firsthand - request a free sample

Get Sample

Get the brochure for pricing and purchase details.

Future Market Insights

Drug Delivery Solutions Market